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Abstract Sensitivity of mammalian cells to the bacterial toxin
aerolysin is due to the presence at their surface of glycosylphos-
phatidyl inositol (GPI)-anchored proteins which act as receptors.
Using a panel of mutants that are affected in the GPI
biosynthetic pathway and Trypanosoma brucei variant surface
glycoproteins, we show that addition of an ethanolamine
phosphate residue on the first mannose of the glycan core
does not affect binding. In contrast, the addition of a side chain
of up to four galactose residues at position 3 of this same
mannose leads to an increase in binding. However, protein free
GPIs, which accumulate in mutant cells deficient in the
transamidase that transfers the protein to the pre-formed
GPI-anchor, were unable to bind the toxin indicating a
requirement for the polypeptide moiety, the nature and size of
which seem of little importance although two exceptions have
been identified. ß 2002 Federation of European Biochemical
Societies. Published by Elsevier Science B.V. All rights re-
served.
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1. Introduction
Aerolysin is one of the major virulence factors produced by
Aeromonas hydrophila [1]. It has no enzymatic activity but has
the capacity to form pores in the plasma membrane of targets
cells [2]. All mammalian cells so far tested are sensitive to
aerolysin due to the ubiquitous expression of its receptors.
Interestingly, aerolysin does not appear to bind to a speci¢c
polypeptide chain since it recognizes a post-translational mod-
i¢cation, a glycosylphosphatidyl inositol (GPI) anchor [3^5].
This anchor is added, in the endoplasmic reticulum, to the
carboxy-terminus of newly synthesized proteins that bear a
GPI-anchoring signal [6,7]. The GPI anchor then targets these
proteins to the plasma membrane. All anchors, from yeast to
mammals, have the same backbone structure consisting of
ethanolamine-HPO4-6ManK1-2ManK1-6ManK1-4GlcNH2K1-
6-myo-inositol-1HPO4 linked to a lipid moiety (Fig. 1A).
Whereas in some parasites such as Leishmania this represents
the complete anchor, the core is modi¢ed by one or more side
chains in trypanosomes and mammalian cells [8]. The GPI
anchor appears to be necessary for aerolysin binding since
addition of a mammalian anchor to cathepsin D, which is
unable to bind the toxin, was shown to transform this protein
into an aerolysin binding protein [5]. The naked anchor (hav-
ing no side chain modi¢cations), consisting only of the con-
served core, however, appeared to be insu⁄cient for binding.
Diep et al. [5] indeed failed to detect binding of aerolysin on
blots of the Leishmania GPI-anchored protein gp63 when ex-
pressed in the parasite, whereas binding on blots was observed
when gp63 was expressed in Chinese hamster ovary (CHO)
cells. Our interest here was to study the sugar modi¢cations
within the GPI anchor that are required for aerolysin bind-
ing.
2. Materials and methods
2.1. Cells and materials
Baby hamster kidney (BHK), HeLa, CHO, F9 and K562 cells were
grown as previously described [4,9^12]. Pig-a (F9 Pig-a), Gaa1 (F9
Gaa1) and Pig-n (F9 Pig-n) knockout F9 cells were generated by
means of homologous recombination [11,13]. They are respectively
de¢cient in the enzyme that transfers GlcNAc from UDP-GlcNAc
to phosphatidyl inositol (Pig-a), in a component of the GPI trans-
amidase complex (Gaa1), and in the enzyme responsible for the addi-
tion of a phosphoethanolamine to the ¢rst mannose of the GPI pre-
cursor (Pig-n). Class A and class K GPI-anchor-de¢cient K562 cells
[12,14] were gifts from S. Hirose and M.E. Medof (Case Western
Reserve University, Cleveland, OH, USA). CHO IIIB2A were ob-
tained after stable transfection of CHO cells with the human CD55
and CD59 cDNAs [15].
Proaerolysin was puri¢ed [4,16] and labeled with Alexa 546 accord-
ing to the manufacturer’s instructions (Molecular Probes) or with 125I
(Amersham Pharmacia Biotech) as previously described [4]. Proaero-
lysin was treated with trypsin (1:20, enzyme protein ratio) for 10 min
at room temperature leading to aerolysin. Soluble forms of two var-
iable surface glycoprotein (VSG) variants, sVSG117 and sVSG118,
were puri¢ed from trypanosomes as described [17] with minor mod-
i¢cations [18]. In contrast to the 118 variant [19], the sVSG117 variant
has a side chain of up to four galactose residues at position 3 of the
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¢rst mannose (Fig. 1A) [20]. Anti-CD52, anti-Thy-1 and anti-CD59
antibodies were gifts from H. Waldmann (Oxford) [21], C. Bron (Lau-
sanne) [22] and M. Tomita [23], respectively. Puri¢ed gp63 from
Leishmania major L119 was a gift from Dr. K. Herrmann (IBFH,
Leipzig, Germany).
2.2. Proaerolysin binding
Con£uent cells were washed three times with ice-cold PBS contain-
ing 1 mM CaCl2 and 1 mM MgCl2 (PBS2). Cells were then incu-
bated at 4‡C with 0.4 nM aerolysin or 0.96 nM [125I]aerolysin in
incubation medium (IM) containing Glasgow minimal essential me-
dium bu¡ered with 10 mM HEPES, pH 7.4, for 1 h. Cells were
washed three times for 5 min with PBS2 at 4‡C. Cells were subse-
quently washed with ice-cold PBS2, scraped from the dish, and col-
lected by centrifugation. The presence of cell-bound aerolysin was
analyzed by Western blotting and that of cell-bound [125I]proaerolysin
by counting.
2.3. Transfection and immuno£uorescence
In order to analyze the ability of aerolysin to bind to CD52, the
human CD52 DNA was cloned in the eukaryotic expression vector
pcDNA3, puri¢ed using Quiagen columns and transfected into HeLa
cells using the Fugene transfection reagent (Roche). The presence of
aerolysin binding components in various cell types (transfected or not)
was analyzed by £uorescence microscopy in the following manner.
Cells grown on cover slips were ¢xed with 3% paraformaldehyde,
permeabilized or not with 0.1% saponin and labeled with 7.5 nM
Alexa^aerolysin. Fluorescence microscopy was carried out using an
inverted Axiovert 135 TV Zeiss microscope equipped with a cooled-
CCD camera (Princeton Instruments), driven by the IP lab imaging
system software.
2.4. Potassium e¥ux measurements
Potassium e¥ux measurements were performed as described [4].
Brie£y, con£uent cell monolayers were incubated with aerolysin for
various times at 37‡C in IM, then washed with ice-cold potassium-free
choline medium, pH 7.4, containing 129 mM choline^Cl, 0.8 mM
MgCl2, 1.5 mM CaCl2, 5 mM citric acid, 5.6 mM glucose, 10 mM
NH4Cl, 5 mM H3PO4 and solubilized with 0.5% Triton X-100 in the
same bu¡er for 20 min at 4‡C. The potassium content of the cell
lysates was determined by £ame photometry using a Philips PYE
UNICAM SP9 atomic absorption spectrophotometer. The intracellu-
lar potassium is calculated as a fraction of potassium content of un-
treated cells.
2.5. Analytical techniques
SDS^PAGE was performed using the Laemmli bu¡er system. Aero-
lysin overlays were performed as previously described [4,10]. Overlays
can be indi¡erently performed with proaerolysin and aerolysin. For
reasons of clarity the term aerolysin will be used throughout the text.
After performing overlays using [125I]aerolysin, binding was quanti¢ed
using a Bio-Rad phosphorimager (Molecular Imager FX) driven by
the Quantify One (v 4.2.1) software. Protein concentrations of cellular
fractions were determined with bicinchoninic acid (Pierce). Labeling
of GPI anchors with [3H]mannose (Amersham Pharmacia Biotech)
was performed as described by Hirose et al. [14]. Potassium e¥ux
was measured using the £uorescent dye PBFI (potassium binding
benzofuran isophthalate) as previously described [24].
Fig. 1. E¡ect of the Pig-n mutation on binding and channel formation by aerolysin. A: Chemical structure of the GPI glycan core. Two,
amongst the many, glycan core modi¢cations are indicated: addition of an EtNP on the ¢rst mannose such as in many mammalian anchors,
and addition of a four-galactose residue side chain on the ¢rst mannose as in VSG117. B: Aerolysin-induced potassium e¥ux from wild type,
Pig-n but not Pig-a and Gaa1 mutant F9 cells. Cells were incubated for various times with 0.1 or 0.4 nM aerolysin. The intracellular potassium
content was then determined by £ame photometry (n = 3, error bars represent standard deviations). C: Aerolysin binds to wild type and F9
Pig-n cells. Wild type and Pig-n mutant F9 cells were incubated with 0.4 nM aerolysin for 1 h at 4‡C. Post-nuclear supernatants were then pre-
pared and analyzed by Western blotting for the presence of aerolysin (the double bands represent the precursor aerolysin and mature furin-
cleaved aerolysin). Binding to F9 Pig-a was used as a negative control. The levels of Thy-1 expression of these cells were probed by Western
blotting. D: Binding of aerolysin to extracts of wild type and F9 Pig-n cells was analyzed by toxin overlay on dot blots of cell extracts. Over-
lays were performed using [125I]aerolysin and binding was quanti¢ed (n = 3, error bars represent standard deviations).
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3. Results
3.1. The role of GPI-anchor mannose modi¢cations in
aerolysin binding
In order to identify the sugar modi¢cations required for
aerolysin binding to the GPI anchor, we ¢rst analyzed a mu-
tant cell line, F9 Pig-n, a¡ected in the Pig-n gene. These cells
express GPI anchors that have no ethanolamine phosphate
(EtNP) group on the ¢rst mannose [13] (Fig. 1A), whereas
most wild type mammalian anchors do. To test whether mu-
tant cells were still sensitive to the toxin, we measured aero-
lysin-induced potassium e¥ux. Both wild type and mutant F9
cells were sensitive to aerolysin, in contrast to GPI-de¢cient
F9 Pig-a cells, that are a¡ected in the ¢rst step of GPI bio-
synthesis [6] (Fig. 1B). The kinetics of potassium e¥ux were
however slower for F9-Pig-n cells, in agreement with the pre-
vious observation that these cells express lower amounts of
Fig. 2. Aerolysin binds to GPI-anchored proteins with naked an-
chors. The ability of aerolysin to bind to 200 ng of puri¢ed trypa-
nosomal sVSG117, sVSG118 and to gp63 from Leishmania was ana-
lyzed by toxin overlay either after SDS^PAGE or after dot blotting
the proteins (A). B: Binding of [125I]aerolysin to sVSG117 and
sVSG118 on dot blots was quanti¢ed (n = 3, error bars represent
standard deviations). C: CHO cells were transfected with the Leish-
mania gp63 gene. Transfected cells were identi¢ed by labeling with
an anti-gp63 antibody. When paraformaldehyde-¢xed cells were co-
labeled with 7.5 nM Alexa-aerolysin, transfected cells did not show
any increase in aerolysin binding. Bar = 10 Wm.
Fig. 3. Aerolysin does not bind to free GPIs. A: Binding of Alexa-
labeled aerolysin to wild type and Gaa1 mutant F9 cells was ana-
lyzed by £uorescence microscopy. Cells were ¢xed with 3% para-
formaldehyde, permeabilized or not with 0.1% saponin and labeled
with 7.5 nM Alexa-aerolysin. B: Sensitivity to aerolysin was ana-
lyzed by measuring the permeabilization of the plasma membrane to
potassium using the K-sensitive dye PBFI. Aerolysin was added at
the time indicated by the arrow (100 ng/ml). C: Binding of aerolysin
to cell extracts of wild type, Pig-a and Gaa1 mutant F9 cells as well
as to wild type class A and class K K562 cells was analyzed by tox-
in overlay on dot blots. In order to load the same amounts of GPI
anchors, irrespective of the presence or absence of attached proteins,
cells were labeled with [3H]mannose in the presence of tunicamycin
and equal counts were dot blotted. D: Binding of [125I]aerolysin
was quanti¢ed (n = 3, error bars represent standard deviations).
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Thy-1 [13] and probably other GPI-anchored proteins. That
aerolysin did bind to F9 Pig-n cells was con¢rmed by £uores-
cence analysis of cells that had been incubated with £uores-
cent aerolysin (not shown), by Western blot analysis of total
cell extracts (Fig. 1C) and by aerolysin overlay of dot blots of
cell extracts (Fig. 1D). In this latter experiment, cells were
labeled with [3H]mannose in the presence of tunicamycin in
order to speci¢cally label GPI anchors. The same number of
counts were dot blotted, presumably corresponding to the
same total amount of GPI anchors. Quanti¢cation indicates
that binding to wild type and Pig-n F9 is very similar, indicat-
ing that the ethanolamine residue at position 2 of the ¢rst
mannose is not essential for binding of aerolysin to the glycan
core and does not a¡ect the a⁄nity of the toxin for the an-
chor.
In order to con¢rm that modi¢cation of the ¢rst mannose
residue is not mandatory for aerolysin binding, we made use
of the observation that aerolysin binds, in vitro, to the VSG
of bloodstream forms of Trypanosoma brucei [5] and of the
availability of well-characterized variants of this protein [25].
The sVSG117 variant was shown to have a single modi¢cation
at the conserved core, i.e. a side chain of up to four galactose
residues at position 3 of the ¢rst mannose (Fig. 1A) [20],
which is absent from the 118 variant [19]. As shown in Fig.
2, aerolysin binds to both variants. Binding is however far
more pronounced with the 117 variant, suggesting that the
modi¢cation at position 3 of the ¢rst mannose increased the
binding a⁄nity.
Interestingly, binding to sVSG118 also reveals that aeroly-
sin is able to bind to a naked anchor EtNP^Man3GlcN-PI
with no side chain modi¢cations. Aerolysin was however un-
able to bind on blots of Leishmania gp63, a GPI-anchored
protein that also has a naked anchor [26] (Fig. 2), in agree-
ment with previous observation [5]. Similarly, we were unable
to detect an increase in binding of aerolysin to CHO cells
overexpressing Leishmania gp63 (Fig. 2C), indicating that
even with a mammalian anchor (i.e. with side chain modi¢ca-
tions), surface-expressed gp63 was not binding competent.
3.2. Aerolysin does not bind to free GPIs
Since the GPI anchor appears to be necessary for aerolysin
binding [5], we next investigated whether it was su⁄cient for
binding, i.e. can aerolysin bind to free GPIs. These glycolipid
intermediates accumulate in cells, such as F9 Gaa1 mutants,
that are de¢cient in the transamidase complex involved in
adding the protein moiety onto the pre-formed GPI anchor
[11]. Free GPIs are found intracellularly but also reach the
extracellular lea£et of the plasma membrane [27]. Despite the
documented presence of free GPIs at the cell surface, we
found that F9 Gaa1 mutants were not sensitive to aerolysin
(Fig. 1B). Also, we were unable to detect any labeling on ¢xed
and permeabilized F9 Gaa1 mutant cells using an aerolysin
£uorescent derivative, in contrast to what is observed on wild
type cells (Fig. 3A), indicating that aerolysin is also incapable
of binding to intracellular free GPIs. Finally, we also failed to
detect signi¢cant binding by toxin overlay on dot blots of cell
extracts (Fig. 3C,D). In these experiments, cells were labeled
with radioactive mannose in the presence of tunicamycin in
order to label GPI anchors, and equal counts were dot blot-
ted. These experiments indicate that aerolysin is unable to
bind to free GPIs. Similarly, human leukemic K562 cells de-
¢cient in the GPI transamidase were resistant to aerolysin
(Fig. 3B) and the toxin failed to bind to extracts of these cells
after dot blot (Fig. 3C,D).
3.3. The protein moiety of the GPI-anchored polypeptide is
required for aerolysin binding
The above-described experiments show that the GPI anchor
is not su⁄cient for aerolysin binding and that the protein
needs to be present. We next tested whether the toxin was
able to bind to the smallest known GPI-anchored protein
CD52 that is composed of only 12 amino acids [28]. HeLa
cells were transfected with the human CD52 gene, ¢xed, and
incubated with Alexa labeled aerolysin. As shown in Fig. 4A,
transfected cells were characterized by a dramatically in-
creased aerolysin binding. A more than two-fold increase in
Fig. 4. Aerolysin binds to CD52 but not to CD59. A,B: HeLa cells
were transfected with the human CD52 gene. Transfected cells were
identi¢ed by labeling with an anti-CD52 antibody (A). When para-
formaldehyde-¢xed cells were co-labeled with 7.5 nM Alexa-aeroly-
sin, transfected cells showed dramatically increased aerolysin binding
(A). B: The e¡ect on CD52 transfection on binding of
[125I]aerolysin to living cells was quanti¢ed (n = 6, error bars repre-
sent standard deviations). Note that the e⁄ciency of transfection
into these HeLa cells was approx. 60%. C: Extracts of CHO cells
stably transfected (CHO IIIB2A, labeled III) [15] or not (WT) with
the human CD55 and CD59 genes were analyzed by aerolysin over-
lay and Western blotting using an anti-CD59 antibody. An extract
from cells de¢cient in GPI biosynthesis (CHO M2S2, labeled M)
were analyzed as a control.
FEBS 25763 8-2-02
L. Abrami et al./FEBS Letters 512 (2002) 249^254252
binding of [125I]aerolysin to living CD52 transfected cells was
observed (transfection rateW60%; Fig. 4B). This observation
however does not imply that all GPI-anchored proteins of 12
amino acids or more will bind aerolysin. Indeed, during the
course of our studies, we encountered two GPI-anchored pro-
teins that were unable to act as an aerolysin receptor: gp63, as
mentioned above, and CD59. We were unable to detect CD59
by aerolysin overlays on extracts of CHO cells stably trans-
fected with the human CD59 gene [15], whereas CD55, the
gene of which had been co-transfected was readily labeled
(Fig. 4C).
4. Discussion
Previous observations have shown that the presence of a
GPI anchor is required for aerolysin binding [3^5]. Binding
will occur in the absence of the lipid moiety of the anchor as
illustrated here by the binding of aerolysin to sVSGs, which
had their diacylglycerol moieties removed by PI-PLC (Fig. 2)
in agreement with previous observations [4,5]. Here we show
that naked anchors are binding competent, but that certain
modi¢cations of the ¢rst mannose of the conserved core can
modulate binding. Addition of an EtNP group at position 2
had no e¡ect. In contrast, binding was promoted by the pres-
ence of an up to four-galactose side chain at position 3.
Despite its importance, the GPI anchor alone is not su⁄-
cient for aerolysin binding as indicate by the absence of bind-
ing to free GPIs. This ¢nding came somewhat as a surprise,
since aerolysin was shown to bind to a variety of GPI-an-
chored proteins that have no sequence homology, such as
thy-1 [3], contactin [5], and CD14 (Fivaz et al., submitted).
More strikingly, we have shown that in BHK cells aerolysin
binds to all GPI-anchored proteins (approx. 10) (Fivaz et al.,
submitted). These observations strongly suggest that the toxin
does not discriminate between the proteins present on the
GPI-anchors. We however believe that GPI-anchored proteins
that do not allow aerolysin binding remain the exception since
we have only encountered two such proteins during the course
of our studies, CD59 and gp63.
The lack of sequence homology between identi¢ed aerolysin
binding proteins suggests that there is not direct contact be-
tween the toxin and the polypeptide chain. To explain the role
of the protein moiety in aerolysin binding, at least four, not
mutually exclusive, possibilities can be proposed. (1) Aeroly-
sin could recognize some post-translational modi¢cation. This
could be N-linked glycosylation since most if not all known
GPI-anchored proteins are glycosylated and often heavily gly-
cosylated. The position of the N-linked sugars would however
have some importance since both CD59 and gp63 are glyco-
sylated [29,30] but neither one permits toxin binding. (2) The
conformation of the GPI anchor that allows aerolysin binding
is acquired only when a polypeptide is attached. This is not
unlikely since the lipid moiety has been shown to in£uence the
antigenicity of some GPI-anchored proteins [28,31,32]. There-
fore, lipid, glycan core and polypeptide appear to in£uence
each other’s structure. The conformation of the glycan core
could then di¡er depending on the structure of this polypep-
tide and some rare conformations would not allow aerolysin
binding. (3) The amide bond between the GPI anchor and the
protein C-terminus or (4) the higher order assembly (multi-
merization for example) of the GPI-anchored proteins could
be important for aerolysin binding. This later possibility is
suggested by the fact that aerolysin was found to bind to
gp63 expressed in CHO cells on blots [5] but not on living
cells (Fig. 2C). These issues await further investigations and
hopefully the analysis of aerolysin-resistant mutant cells will
allow the unraveling of aerolysin binding determinants.
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